Response to "No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: A retrospective cohort study".

Desai, Deesha; Sikora, Michelle; Nohria, Ambika; Caplan, Avrom S; Lacouture, Mario; Shapiro, Jerry; Lo Sicco, Kristen I

Desai, Deesha; Sikora, Michelle; Nohria, Ambika; Caplan, Avrom S; Lacouture, Mario; Shapiro, Jerry; Lo Sicco, Kristen I.

Afiliación

Desai D; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York. Electronic address: deesha.desai@nyulangone.org.
Sikora M; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York; New York Medical College, Valhalla, New York.
Nohria A; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
Caplan AS; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
Lacouture M; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
Shapiro J; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
Lo Sicco KI; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.

J Am Acad Dermatol ; 2024 Aug 20.

Article en En | MEDLINE | ID: mdl-39168312

Palabras clave

breast cancer; malignancy; risk assessment; spironolactone

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Am Acad Dermatol / J. Am. Acad. Dermatol / Journal of the American Academy of dermatology Año: 2024 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google